Oncology Highlights - September 2018
Nobel prize in medicine goes for cancer immunotherapy, linking sugar to cancer, Roche acquires Tusk, FDA guidelines on adaptive trials and more
Oncology Highlights - August 2018
Future is now: digital diagnostic apps, artificial intelligence to predict responders. PD-L1 exosomes, M&A news in oncology
Oncology Highlights - July 2018
Mistimed meals and increased risk of cancer, how reward mechanism boosts immunity, rapid gene editing, European VC climb, IO/IO combination approvals
Oncology Highlights - June 2018
Novel ACT therapy, Vitamin D and lowered cancer risk, iTeos secures $75M, EMA guidance on Brexit
Oncology Highlights - May 2018
Achilles heel in drug-resistant cancer, smart Nanobombs, Lilly's IO spree, Xenikos secure Series B funding..
Combination immunotherapy: The latest revolution in cancer treatment
An analysis of the clinical landscape The present focus in the treatment of cancer is immunotherapy, in particular immunotherapies that are trialed in a combination regimen. By combining immuno-oncology (IO) agents with oth...
ASCO 2018 recap - pembro the way to go?
The 2018 Annual Meeting of the American Society of Clinical Oncology (ASCO) gathered over 32.000 oncology professionals from all over the world, highlighting the latest in cancer care treatments.
AACR2018 - Emerging trends in next generation immunotherapy
Chicago hosted the 2018 annual meeting of the American Association for Cancer Research (AACR) in its cold spring days. As expected, enthusiasm centered on immunotherapy combination therapy and its challenges, and the possibilit...
The future of data management in clinical trials - ACDM 2018
On March 13, Brussels was considered the capital of Data Management, hosting the annual conference of the Association for Clinical Data Management (ACDM). Since technologies and standards continue to evolve in the ever changing...
Power of targeted, personalized and combined therapies - TAT 2018
The home of Phase I oncology conference a.k.a. the Targeted Anticancer Therapies (TAT) conference took place this week in the beautiful city of Paris. The program is dedicated to early-phase development and translational resear...